Trial NCT00899431

View at ClinicalTrials.gov 
Org. Study IDs: 2007-0871
Secondary IDs: NCI-2012-01620

Last trial update was posted on 2020-01-27

MeSH Interventions

Allopurinol Antilymphocyte Serum Bendamustine Hydrochloride Fludarabine Fludarabine phosphate Lenalidomide Rituximab Thymoglobulin

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid

Other Conditions

Chronic Lymphocytic Leukemia

Stopping Reasons

Terminated per PI's request at the time of continuing review

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID